Literature DB >> 20934996

Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age.

Emilie Castermans1, Muriel Hannon, Jacques Dutrieux, Stéphanie Humblet-Baron, Laurence Seidel, Rémi Cheynier, Evelyne Willems, André Gothot, Jean-François Vanbellinghen, Vincent Geenen, Brenda M Sandmaier, Rainer Storb, Yves Beguin, Frédéric Baron.   

Abstract

BACKGROUND: Long-term immune recovery in older patients given hematopoietic cell transplantation after non-myeloablative conditioning remains poorly understood. This prompted us to investigate long-term lymphocyte reconstitution and thymic function in 80 patients given allogeneic peripheral blood stem cells after non-myeloablative conditioning. DESIGN AND METHODS: Median age at transplant was 57 years (range 10-71). Conditioning regimen consisted of 2 Gy total body irradiation (TBI) with (n=46) or without (n=20) added fludarabine, 4 Gy TBI with fludarabine (n=6), or cyclophosphamide plus fludarabine (n=8). Stem cell sources were unmanipulated (n=56), CD8-depleted (n=19), or CD34-selected (n=5) peripheral blood stem cells. Immune recovery was assessed by signal-joint T-cell receptor excision circle quantification and flow cytometry.
RESULTS: Signal-joint T-cell receptor excision circle levels increased from day 100 to one and two years after transplantation in patients under 50 years of age (n=23; P=0.02 and P=0.04, respectively), and in those aged 51-60 years (n=35; P=0.17 and P=0.06, respectively), but not in patients aged over 60 (n=22; P=0.3 and P=0.3, respectively). Similarly, CD4(+)CD45RA(+) (naïve) T-cell counts increased from day 100 to one and two years after transplantation in patients aged 50 years and under 50 (P=0.002 and P=0.02, respectively), and in those aged 51-60 (P=0.4 and P=0.001, respectively), but less so in patients aged over 60 (P=0.3 and P=0.06, respectively). In multivariate analyses, older patient age (P<0.001), extensive chronic GVHD (P<0.001), and prior (resolved) extensive chronic graft-versus-host disease (P=0.008) were associated with low signal-joint T-cell receptor excision circle levels one year or more after HCT.
CONCLUSIONS: In summary, our data suggest that thymic neo-generation of T cells occurred from day 100 onwards in patients under 60 while signal-joint T-cell receptor excision circle levels remained low for patients aged over 60. Further, chronic graft-versus-host disease had a dramatic impact on thymic function, as observed previously in patients given grafts after myeloablative conditioning.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20934996      PMCID: PMC3031699          DOI: 10.3324/haematol.2010.029702

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  54 in total

Review 1.  The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection.

Authors:  B F Haynes; M L Markert; G D Sempowski; D D Patel; L P Hale
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Current concepts of thymic aging.

Authors:  Terry J Fry; Crystal L Mackall
Journal:  Springer Semin Immunopathol       Date:  2002

3.  Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation.

Authors:  J Storek; D Wells; M A Dawson; B Storer; D G Maloney
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

4.  Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype.

Authors:  Marina Cavazzana-Calvo; Frédérique Carlier; Françoise Le Deist; Estelle Morillon; Pierre Taupin; David Gautier; Isabelle Radford-Weiss; Sophie Caillat-Zucman; Bénédicte Neven; Stephane Blanche; Rémi Cheynier; Alain Fischer; Salima Hacein-Bey-Abina
Journal:  Blood       Date:  2007-02-01       Impact factor: 22.113

5.  Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation.

Authors:  K Weinberg; B R Blazar; J E Wagner; E Agura; B J Hill; M Smogorzewska; R A Koup; M R Betts; R H Collins; D C Douek
Journal:  Blood       Date:  2001-03-01       Impact factor: 22.113

6.  Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity.

Authors:  E Roux; F Dumont-Girard; M Starobinski; C A Siegrist; C Helg; B Chapuis; E Roosnek
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

7.  Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation.

Authors:  J Storek; M A Dawson; B Storer; T Stevens-Ayers; D G Maloney; K A Marr; R P Witherspoon; W Bensinger; M E Flowers; P Martin; R Storb; F R Appelbaum; M Boeckh
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

8.  Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.

Authors:  P A McSweeney; D Niederwieser; J A Shizuru; B M Sandmaier; A J Molina; D G Maloney; T R Chauncey; T A Gooley; U Hegenbart; R A Nash; J Radich; J L Wagner; S Minor; F R Appelbaum; W I Bensinger; E Bryant; M E Flowers; G E Georges; F C Grumet; H P Kiem; B Torok-Storb; C Yu; K G Blume; R F Storb
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

9.  Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults.

Authors:  E P Hochberg; A C Chillemi; C J Wu; D Neuberg; C Canning; K Hartman; E P Alyea; R J Soiffer; S A Kalams; J Ritz
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

10.  T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events.

Authors:  Mette D Hazenberg; Sigrid A Otto; Elmar S de Pauw; Helene Roelofs; Willem E Fibbe; Dörte Hamann; Frank Miedema
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

View more
  35 in total

Review 1.  Thymus involution and regeneration: two sides of the same coin?

Authors:  Thomas Boehm; Jeremy B Swann
Journal:  Nat Rev Immunol       Date:  2013-09-20       Impact factor: 53.106

2.  Impact of irradiation and immunosuppressive agents on immune system homeostasis in rhesus macaques.

Authors:  C Meyer; J Walker; J Dewane; F Engelmann; W Laub; S Pillai; Charles R Thomas; I Messaoudi
Journal:  Clin Exp Immunol       Date:  2015-06-29       Impact factor: 4.330

Review 3.  Thymic T-cell development in allogeneic stem cell transplantation.

Authors:  Werner Krenger; Bruce R Blazar; Georg A Holländer
Journal:  Blood       Date:  2011-03-22       Impact factor: 22.113

4.  Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene.

Authors:  Xiaoou Zhou; Antonio Di Stasi; Siok-Keen Tey; Robert A Krance; Caridad Martinez; Kathryn S Leung; April G Durett; Meng-Fen Wu; Hao Liu; Ann M Leen; Barbara Savoldo; Yu-Feng Lin; Bambi J Grilley; Adrian P Gee; David M Spencer; Cliona M Rooney; Helen E Heslop; Malcolm K Brenner; Gianpietro Dotti
Journal:  Blood       Date:  2014-04-21       Impact factor: 22.113

Review 5.  Reduced-intensity conditioned allogeneic SCT in adults with AML.

Authors:  R Reshef; D L Porter
Journal:  Bone Marrow Transplant       Date:  2015-03-02       Impact factor: 5.483

Review 6.  Reconstitution of adaptive immunity after umbilical cord blood transplantation: impact on infectious complications.

Authors:  Sophie Servais; Muriel Hannon; Régis Peffault de Latour; Gérard Socie; Yves Beguin
Journal:  Stem Cell Investig       Date:  2017-05-25

7.  CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse.

Authors:  Roni Tamari; Stephen S Chung; Esperanza B Papadopoulos; Ann A Jakubowski; Patrick Hilden; Sean M Devlin; Jenna D Goldberg; Miguel-Angel Perales; Doris M Ponce; Craig S Sauter; Molly A Maloy; Dara Y Herman; Virginia Klimek; James W Young; Richard J O'Reilly; Sergio A Giralt; Hugo Castro-Malaspina
Journal:  Biol Blood Marrow Transplant       Date:  2015-07-14       Impact factor: 5.742

8.  Chemokine treatment rescues profound T-lineage progenitor homing defect after bone marrow transplant conditioning in mice.

Authors:  Shirley L Zhang; Xinxin Wang; Sugata Manna; Daniel A Zlotoff; Jerrod L Bryson; Bruce R Blazar; Avinash Bhandoola
Journal:  Blood       Date:  2014-05-29       Impact factor: 22.113

9.  Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplant.

Authors:  Zachariah McIver; Jan Joseph Melenhorst; Colin Wu; Andrew Grim; Sawa Ito; Irene Cho; Nancy Hensel; Minoo Battiwalla; Austin John Barrett
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

Review 10.  Understanding immunosenescence to improve responses to vaccines.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Nat Immunol       Date:  2013-04-18       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.